Business
Pfizer raises sales guidance on high demand for older drugs
The Irish TimesDrugmaker plans for another $2.5bn in cost savings as it looks to move beyond post-Covid sales slump
The Irish Times
The Irish TimesDrugmaker plans for another $2.5bn in cost savings as it looks to move beyond post-Covid sales slump